Data / Drug companies / Guaifenesin
Guaifenesin: 123 companies and 293 products in the FDA NDC directory
Guaifenesin is listed in the FDA National Drug Code Directory by 123 companies, with 293 products in commercial distribution. 171 of the products (58.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet; tablet, multilayer, extended release, and the newest product started marketing on October 27, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 123
- Products
- 293
- Generic (ANDA) products
- 171 (58.4%)
- Application numbers
- 12
- Routes
- Oral, Topical
- Brand names
- Mucus Relief, Mucus Relief, Mucinex, Mucus Relief Maximum Strength, Maximum Strength Mucus Relief, Mucus Relief Extended Release Maximum Strength, Chest Congestion Relief, Mucus Relief Extended Release
- openFDA record search
- api.fda.gov
Companies that list guaifenesin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| CVS Woonsocket Prescription Center, Incorporated | 10 | tablet, multilayer, extended release; tablet, extended release | Generic drugs (ANDA) | February 10, 2026 |
| Strategic Sourcing Services LLC | 9 | tablet, extended release; tablet | Generic drugs (ANDA) | September 9, 2026 |
| Walgreen Company | 8 | tablet; tablet, extended release | Generic drugs (ANDA) | July 19, 2024 |
| Rugby Laboratories | 7 | liquid; tablet, extended release | Generic drugs (ANDA) | June 15, 2026 |
| A-S Medication Solutions | 6 | tablet, extended release; liquid | New drug applications (NDA) | May 1, 2019 |
| Aurohealth LLC | 6 | tablet, extended release | Generic drugs (ANDA) | July 3, 2026 |
| Cardinal Health 110, LLC. DBA Leader | 6 | tablet; tablet, multilayer, extended release | Generic drugs (ANDA) | April 8, 2026 |
| Chain Drug Marketing Association, Inc. | 5 | tablet, extended release; syrup | Over the counter monograph drugs | December 2, 2025 |
| Geri-Care Pharmaceuticals, Corp | 5 | tablet; liquid | Over the counter monograph drugs | August 1, 2026 |
| Amazon.com Services LLC | 4 | tablet, multilayer, extended release | Generic drugs (ANDA) | October 15, 2026 |
| Amerisource Bergen | 4 | tablet, multilayer, extended release; syrup | Generic drugs (ANDA) | June 17, 2025 |
| Bryant Ranch Prepack | 4 | tablet; tablet, extended release | Over the counter monograph drugs | February 1, 2021 |
| Cardinal Health 107, LLC | 4 | solution; tablet, extended release | Over the counter monograph drugs | September 30, 2018 |
| Chain Drug Marketing Association | 4 | tablet, extended release; solution | Over the counter monograph drugs | September 17, 2021 |
| Discount Drug Mart | 4 | liquid; tablet, extended release | Over the counter monograph drugs | February 14, 2025 |
| Dolgencorp, Inc. (dollar General & Rexall) | 4 | tablet, multilayer, extended release; tablet | Generic drugs (ANDA) | March 24, 2025 |
| Dr. Reddy's Laboratories Inc. | 4 | tablet, extended release | Generic drugs (ANDA) | September 1, 2022 |
| Granules India Limited | 4 | tablet, extended release | Generic drugs (ANDA) | February 1, 2021 |
| Guardian Drug Company | 4 | tablet, extended release | Generic drugs (ANDA) | June 24, 2020 |
| Pai Holdings, LLC DBA Pai Pharma | 4 | solution | Over the counter monograph drugs | September 1, 2002 |
| Sam's West Inc | 4 | tablet, extended release; tablet | Generic drugs (ANDA) | August 20, 2025 |
| Topco Associates LLC | 4 | tablet, multilayer, extended release; tablet, extended release | Generic drugs (ANDA) | April 22, 2026 |
| Walmart Inc. | 4 | tablet, extended release; tablet, multilayer, extended release | Generic drugs (ANDA) | March 31, 2025 |
| Yyba Corp | 4 | tablet; tablet, extended release | Generic drugs (ANDA) | July 1, 2026 |
| American Health Packaging | 3 | solution | Over the counter monograph drugs | October 20, 2024 |
| Bi-Mart | 3 | tablet; tablet, extended release | Generic drugs (ANDA) | May 1, 2025 |
| CVS Pharmacy | 3 | tablet, extended release; tablet | Generic drugs (ANDA) | March 1, 2021 |
| Efficient Laboratories Inc | 3 | liquid; syrup | Over the counter monograph drugs | September 1, 2026 |
| Family Dollar (family Wellness) | 3 | tablet, extended release; tablet | Generic drugs (ANDA) | April 1, 2025 |
| H E B | 3 | tablet; tablet, extended release | Generic drugs (ANDA) | June 5, 2023 |
| HyVee Inc | 3 | tablet, multilayer, extended release; tablet, extended release | Generic drugs (ANDA) | March 10, 2026 |
| Kroger Company | 3 | tablet, extended release; tablet | Generic drugs (ANDA) | April 28, 2022 |
| Kroger Company | 3 | tablet, extended release; tablet | Generic drugs (ANDA) | May 27, 2024 |
| L. Perrigo Company | 3 | tablet, multilayer, extended release | Generic drugs (ANDA) | April 24, 2025 |
| Major Pharmaceuticals | 3 | tablet, extended release; tablet | Generic drugs (ANDA) | September 23, 2019 |
| Meijer, Inc. | 3 | tablet; tablet, extended release | Over the counter monograph drugs | March 14, 2025 |
| Reckitt Benckiser LLC | 3 | tablet, extended release; solution | New drug applications (NDA) | June 1, 2020 |
| Redpharm Drug | 3 | tablet; tablet, multilayer, extended release | Generic drugs (ANDA) | March 15, 2022 |
| Safeway | 3 | tablet, extended release; tablet | Generic drugs (ANDA) | June 30, 2023 |
| Target Corporation | 3 | tablet; tablet, multilayer, extended release | Generic drugs (ANDA) | August 1, 2024 |
| Time Cap Laboratories, Inc | 3 | tablet | Generic drugs (ANDA) | January 8, 2024 |
| WinCo Foods, LLC | 3 | tablet, extended release; tablet | Generic drugs (ANDA) | April 11, 2023 |
| Advanced Rx LLC | 2 | tablet, extended release | Generic drugs (ANDA) | December 18, 2020 |
| Akron Pharma Inc. | 2 | liquid | Over the counter monograph drugs | November 3, 2023 |
| American Sales Company | 2 | tablet | Generic drugs (ANDA) | December 31, 2018 |
| Amneal Pharmaceuticals LLC | 2 | tablet, extended release | Generic drugs (ANDA) | July 27, 2018 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet, extended release; tablet | Generic drugs (ANDA) | September 23, 2019 |
| Bjwc | 2 | tablet, extended release; tablet, multilayer, extended release | Generic drugs (ANDA) | August 20, 2025 |
| Bryant Ranch Prepack | 2 | tablet, extended release | New drug applications (NDA) | July 3, 2012 |
| Demoulas Super Markets, Inc | 2 | tablet, extended release | Generic drugs (ANDA) | October 1, 2022 |
| Dextrum Laboratories, Inc | 2 | solution | Over the counter monograph drugs | June 22, 2020 |
| Farmacias De Similares TX LLC | 2 | tablet, extended release | Over the counter monograph drugs | April 8, 2026 |
| Fsa Store Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | May 2, 2023 |
| Gil Pharmaceutical Corp | 2 | solution | Over the counter monograph drugs | June 22, 2020 |
| Granules USA, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | September 12, 2024 |
| Harris Teeter | 2 | tablet, extended release | Generic drugs (ANDA) | March 1, 2024 |
| Health Pharma USA LLC | 2 | tablet | Over the counter monograph drugs | June 18, 2025 |
| Kesin Pharma Corporation | 2 | liquid | Over the counter monograph drugs | April 1, 2025 |
| Little Pharma, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | February 21, 2022 |
| Llorens Pharmaceutical International Division, Inc. | 2 | liquid | Over the counter monograph drugs | December 1, 2025 |
| Marlex Pharmaceuticals, Inc. | 2 | tablet | Over the counter monograph drugs | March 1, 2024 |
| Meijer Distribution Inc | 2 | tablet, multilayer, extended release; tablet | Generic drugs (ANDA) | August 7, 2020 |
| Method Pharmaceuticals, LLC | 2 | liquid | Over the counter monograph drugs | April 1, 2024 |
| Nuvicare LLC | 2 | tablet, extended release | Generic drugs (ANDA) | December 16, 2025 |
| Ohm Laboratories Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | April 1, 2022 |
| P & L Development, LLC | 2 | tablet, extended release | Generic drugs (ANDA) | February 15, 2025 |
| Pioneer Life Sciences, LLC | 2 | tablet, extended release | Generic drugs (ANDA) | December 22, 2025 |
| Publix Super Markets, Inc | 2 | tablet, extended release | Generic drugs (ANDA) | January 8, 2018 |
| Reese Pharmaceutical Co | 2 | tablet | Over the counter monograph drugs | April 15, 2021 |
| Reliable 1 Laboratories LLC | 2 | liquid; tablet | Over the counter monograph drugs | December 1, 2024 |
| Rite Aid Corporation | 2 | tablet; tablet, extended release | Generic drugs (ANDA) | June 29, 2022 |
| Schwabe North America, Inc. | 2 | tablet | Over the counter monograph drugs | July 29, 2025 |
| Sda Laboratories, Inc. | 2 | liquid; tablet | Over the counter monograph drugs | July 1, 2025 |
| Southern Sales & Service, Inc. | 2 | liquid; solution | Over the counter monograph drugs | February 1, 2023 |
| Topco Associates LLC | 2 | tablet; tablet, extended release | Over the counter monograph drugs | June 1, 2021 |
| Unifirst First Aid Corporation | 2 | liquid | Over the counter monograph drugs | May 1, 2026 |
| United Natural Foods, Inc. DBA Unfi | 2 | tablet | Over the counter monograph drugs | September 30, 2018 |
| Valu Merchandisers Company | 2 | tablet | Over the counter monograph drugs | August 22, 2022 |
| Aaa Pharmaceutical, Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | February 1, 2024 |
| Aarna USA Inc. | 1 | liquid | Over the counter monograph drugs | February 18, 2025 |
| Aldama Pharmaceuticals, Inc | 1 | liquid | Over the counter monograph drugs | June 1, 2026 |
| Allegiant Health | 1 | tablet | Over the counter monograph drugs | December 23, 2014 |
| American Health Packaging | 1 | tablet, extended release | New drug applications (NDA) | February 19, 2016 |
| Amerifoods Trading Company | 1 | tablet, extended release | Generic drugs (ANDA) | November 20, 2025 |
| Amerisource Bergen | 1 | tablet | Over the counter monograph drugs | October 2, 2018 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet, extended release | New drug applications (NDA) | July 3, 2012 |
| Apnar Pharma LP | 1 | tablet | Over the counter monograph drugs | August 5, 2022 |
| AptaPharma Inc. | 1 | liquid | Over the counter monograph drugs | September 30, 2020 |
| Atlantic Biologicals Corp. | 1 | tablet, extended release | New drug applications (NDA) | July 3, 2012 |
| BluePoint Laboratories | 1 | tablet, extended release | Generic drugs (ANDA) | March 15, 2023 |
| Bryant Ranch Prepack | 1 | liquid | Over the counter monograph drugs | April 1, 2024 |
| Camber Consumer Care Inc | 1 | solution | Over the counter monograph drugs | May 19, 2025 |
| Fortune Pharmacal Company Limited | 1 | tablet | Over the counter monograph drugs | July 1, 2025 |
| Gendose Pharmaceuticals, LLC | 1 | tablet | Over the counter monograph drugs | September 2, 2022 |
| Granules Pharmaceuticals Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | August 19, 2022 |
| Grocery Outlet, Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | March 13, 2026 |
| Innovida Pharmaeutique Corporation | 1 | liquid | Over the counter monograph drugs | June 16, 2025 |
| Innovus Pharmaceuticals, Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | October 27, 2026 |
| Lodaat LLC | 1 | tablet | Generic drugs (ANDA) | March 4, 2023 |
| Magno-Humphries, Inc. | 1 | tablet | Over the counter monograph drugs | January 24, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 123 | 42% |
| Tablet | 73 | 24.9% |
| Tablet, multilayer, extended release | 35 | 11.9% |
| Liquid | 33 | 11.3% |
| Solution | 19 | 6.5% |
| Syrup | 8 | 2.7% |
| Tablet, film coated | 2 | 0.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 171 | 58.4% |
| Over the counter monograph drugs | 108 | 36.9% |
| New drug applications (NDA) | 14 | 4.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Expectorant | 288 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.